Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078892 | SCV000337096 | benign | not specified | 2016-05-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000559683 | SCV000650395 | benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000078892 | SCV000730045 | benign | not specified | 2017-03-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV001200490 | SCV001371464 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | PLEC: BP4, BP7, BS2 |
Athena Diagnostics | RCV000078892 | SCV001475382 | benign | not specified | 2024-08-20 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001200490 | SCV005222307 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV001200490 | SCV001741731 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001200490 | SCV001972356 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001200490 | SCV002036677 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004537320 | SCV004731603 | benign | PLEC-related disorder | 2019-07-30 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |